A study of 118 cancer patients at McGill University Health Centre revealed that over half (58.5%) developed ocular complications during chemotherapy or radiotherapy, most commonly dry eye (34.8%) and cataracts (23.7%) . With breast and lung cancers accounting for the majority of cases, the findings emphasize that ocular toxicity is a frequent but under-recognized side effect of cancer treatment. Early ophthalmic evaluation may be crucial to preserving visual function and improving quality of life in this population. To read mor; Click here Should baseline and follow-up eye exams be mandatory for all patients undergoing cancer treatment?
##Reference## Coblentz, Jacqueline; Mastromonaco, Christina; Burnier Jr, Miguel Noel. Ocular findings in patients undergoing cancer treatment. The Pan-American Journal of Ophthalmology 7(1):168, July 2025.##
